Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

BACKGROUND AND AIMS: Immunotherapy with PD-1 inhibitors combined with tyrosine kinase inhibitors (TKIs) has been proven to be effective against advanced hepatocellular carcinoma (HCC). The aim of this study was to identify the feasibility and safety of subsequent salvage surgery after this combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenwen, Hu, Bingyang, Han, Jun, Wang, Zhanbo, Ma, Guangyu, Ye, Huiyi, Yuan, Jing, Cao, Junning, Zhang, Ze, Shi, Jihang, Chen, Mingyi, Wang, Xun, Xu, Yinzhe, Cheng, Yanshuang, Tian, Lantian, Wang, Hongguang, Lu, Shichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560793/
https://www.ncbi.nlm.nih.gov/pubmed/34737958
http://dx.doi.org/10.3389/fonc.2021.747950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560793/
https://www.ncbi.nlm.nih.gov/pubmed/34737958
http://dx.doi.org/10.3389/fonc.2021.747950

Ejemplares similares